Boehringer Ingelheim gets European approval for additional indication for nintedanib in pulmonary fibrosis
Boehringer Ingelheim announced that the EC has approved an additional indication for nintedanib in adults for the treatment of other chronic fibrosing interstitial lung...
RB invests $25 mn to set up new Reckitt Global Hygiene Institute
RB is investing $25 million to set up the Reckitt Global Hygiene Institute (RGHI) which is a research and innovation hub that will bridge...
Heron Therapeutics initiates phase 2 GUARDS-1 study of Cinvanti to treat COVID-19
Heron Therapeutics, a commercial-stage biotechnology company, announced the initiation of the GUARDS-1 Study, a phase 2 clinical study evaluating Cinvanti (aprepitant) injectable emulsion in...
Lilly’s Mirikizumab Superior to Cosentyx in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis
Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the primary and all key...
GSK and CureVac announce strategic mRNA technology collaboration
GlaxoSmithKline plc and CureVac announced the signing of a strategic collaboration agreement for the research, development, manufacturing and commercialisation of up to five mRNA-based...
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic...
Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development
Sanofi and The University of Texas MD Anderson Cancer Center announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...